| 000 | 01162aam a2200337 i 4500 | ||
|---|---|---|---|
| 999 |
_c12897 _d12897 |
||
| 001 | 9929082863602122 | ||
| 005 | 20210307133729.0 | ||
| 008 | 940406s1990 maua 001 0 eng u | ||
| 010 | _a 94142104 | ||
| 020 | _a0962596205 | ||
| 040 |
_aEG-NcFUE _beng _cEG-NcFUE _erda |
||
| 043 | _an-us--- | ||
| 082 | 0 | 4 |
_222 _a363.19460973 _bM.M.N |
| 100 | 1 |
_aMathieu, Mark P. _eauthor. |
|
| 245 | 1 | 0 |
_aNew drug development : _ba regulatory overview / _cMark Mathieu |
| 250 | _aNewly Revised and Updated | ||
| 264 | 1 |
_aWaltham, MA : _bPAREXEL International Corporation, _c[1990] |
|
| 264 | 4 | _c©1990 | |
| 300 |
_aviii, 282 pages : _billustrations ; _c24 cm |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_aunmediated _bn _2rdamedia |
||
| 338 |
_avolume _bnc _2rdacarrier |
||
| 500 | _aIncludes index. | ||
| 610 | 1 | 0 |
_aUnited States. _bFood and Drug Administration. |
| 650 | 0 |
_aPharmaceutical policy _zUnited States. |
|
| 650 | 0 |
_aDrugs _xLaw and legislation _zUnited States. |
|
| 650 | 0 |
_aPharmaceutical industry _zUnited States. |
|
| 942 |
_2ddc _cBK |
||